Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
8.85
0.03 (0.34%)
At close: Aug 15, 2025, 3:59 PM
8.82
-0.28%
After-hours: Aug 15, 2025, 07:40 PM EDT
Emergent BioSolutions Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12M | 68M | -31.3M | 114.8M | -283.1M | 9M | -49.5M | -263.4M | -261.3M | -183M | -88M | -75.7M | -56.4M | -3.7M | 189.3M | -32.7M | 4.6M | 69.7M |
Depreciation & Amortization | 23.5M | 25.4M | 26M | 26.4M | 29.4M | 28.8M | 30.5M | 29.1M | 32.9M | 34.6M | 35.6M | 32.3M | 44.5M | 30.9M | 29.2M | 32.7M | 33.2M | 28.7M |
Stock-Based Compensation | 4.6M | 1.5M | 4.3M | 2.3M | 5.5M | 5.9M | 4M | 4M | 8.3M | 6.8M | 11.7M | 11.2M | 12.3M | 9.9M | 10.1M | 10.4M | 11.4M | 10.5M |
Other Working Capital | n/a | -37.8M | -9M | 24.3M | 195.9M | -40.6M | -8.9M | -12.5M | 1.5M | -40M | 80.4M | -15.1M | -6.3M | -107.3M | 43M | -25.9M | -8.8M | -70M |
Other Non-Cash Items | 104.2M | -6M | 6.8M | -62.7M | 144.3M | 123.8M | 5.8M | 218.6M | 252.7M | 2.8M | 1.3M | 12.5M | 3.9M | 2.1M | -63.4M | 91.2M | 100K | 5.6M |
Deferred Income Tax | -13.9M | 18.6M | -400K | 7.3M | -200K | -12.2M | -5.2M | 6.5M | -1.8M | -8.4M | -42M | 20.4M | 700K | 1.9M | 46.3M | 3.8M | -1.5M | -1.7M |
Change in Working Capital | n/a | -118.7M | -85.3M | 65.6M | 205.9M | -97.5M | 46.5M | 65.2M | -145.2M | -36.8M | 174.2M | -74.7M | -20.6M | -78.4M | 117.5M | -88.7M | -77.5M | -107.7M |
Operating Cash Flow | 106.4M | -11.2M | -79.9M | 153.7M | 47.5M | -62.6M | 32.1M | 60M | -114.4M | -184M | 92.8M | -74M | -15.6M | -37.3M | 329M | 16.7M | -29.7M | 5.1M |
Capital Expenditures | -2.9M | -3.6M | -1.7M | -5.8M | -4.6M | -10.8M | -11.4M | -12.6M | -12.5M | -15.1M | -23.6M | -27.9M | -32.1M | -32.2M | -46.7M | -55.2M | -67M | -56.1M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -270.2M | n/a | 270.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 20.1M | 63.1M | 30.3M | 117.8M | n/a | n/a | 270.2M | -6.3M | 270.2M | n/a | -21.8M | -243.7M | n/a | n/a | n/a | n/a | n/a | -88.6M |
Investing Cash Flow | 17.2M | 59.5M | 28.6M | 112M | -4.6M | -10.8M | -11.4M | -18.9M | 257.7M | -15.1M | -45.4M | -271.6M | -32.1M | -32.2M | -46.7M | -55.2M | -67M | -56.1M |
Debt Repayment | n/a | n/a | n/a | -194M | -51.4M | 41.1M | 4.1M | -42.9M | -496.2M | -8.4M | 351.5M | 229.6M | -8.4M | -8.5M | -8.4M | -5.6M | -5.7M | -16.2M |
Common Stock Repurchased | -6.9M | n/a | n/a | n/a | -200K | -400K | n/a | -100K | n/a | -2.1M | -200K | -300K | -24.4M | -57.5M | -106.3M | -500K | -800K | -12.2M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 500K | -400K | 800K | 4.4M | 500K | -400K | 400K | -100K | 1.1M | -2.1M | 1.8M | -300K | 2.1M | -4.5M | 1M | 600K | 1.9M | -6M |
Financial Cash Flow | -6.4M | -400K | 500K | -180.3M | -50.9M | 40.7M | 4.7M | -43M | -486.9M | -10.5M | 353.1M | 229.3M | -30.7M | -70.5M | -110M | -5M | -3.8M | -22.2M |
Net Cash Flow | 118.2M | 47.2M | -50.8M | 85.4M | -8M | -32.7M | 23.9M | -90.5M | -341.6M | -212.4M | 401.6M | -117.3M | -77.7M | -140.3M | 172.3M | -43.7M | -100.3M | -73.5M |
Free Cash Flow | 103.5M | -14.8M | -81.6M | 147.9M | 42.9M | -73.4M | 20.7M | 47.4M | -126.9M | -199.1M | 69.2M | -101.9M | -47.7M | -69.5M | 282.3M | -38.5M | -96.7M | -51M |